Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Vaidya, Ankur; Asati, Vivek

Elsevier Science & Technology

04/2024

502

Mole

Inglês

9780323961219

15 a 20 dias

Descrição não disponível.
1. Activin receptor-like kinase-2 (ALK2)
2. Ataxia telangiectasia and Rad3-related protein?(ATR)
3. Breakpoint cluster region protein (BCR-AbL)
4. Casein kinase (CK)
5. c-Src kinase/Src-Abl
6. Cyclin dependent kinase 4 and 6
7. Epidermal growth factor receptor (EGFR)
8. Fyn-Blk-Lyn
9. Insulin-like growth factor (IGFs)
10. Mitotic kinesin spindle protein (KSP/Eg5 ATPase)
11. p21-activated kinase 1 (PAK1)
12. p38 mitogen-activated protein (MAP) kinase
13. Proviral integration site for Moloney murine leukemia virus-1?(PIM-1) kinase
14. Rearranged during Transfection (RET)
15. Serine/threonine-protein kinase B-Raf
16. Tubulin polymerization
17. Tumor necrosis factor receptor associated protein 1 (TRAP1)
18. Vascular Endothelial Growth Factor Receptors (VEGFR/PDGFR)
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Cancer; molecular target; protein kinase; ALK2; ATR; CK; Src-Abl; EGFR; Fyn-Blk-Lyn; IGFs; PAK1; cancer treatment; tumor development